好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Post-Traumatic Progressive Myelopathy Presenting with Longitudinally Extensive Transverse Myelitis Following a Penetrating Stab Wound
Autoimmune Neurology
Autoimmune Neurology Posters (7:00 AM-5:00 PM)
112

To present a case of acute on chronic post-traumatic progressive myelopathy presenting with clinical and radiological longitudinally extensive transverse myelitis (LETM).

LETM is part of a larger spectrum of central nervous system inflammatory disorders characterized by immune-mediated demyelination that may suggest an underlying diagnosis of neuromyelitis optica spectrum disorder (NMOSD) or similar mimics. Trauma may also manifest with cord signal changes that suggest underlying demyelination, and is an important differential to consider.

Case report from a tertiary medical center.

A 31-year old male presented with rapidly progressive paraparesis, T1 sensory level, brisk LE reflexes and urinary retention after lifting heavy weights. MRI showed extensive longitudinal cord enhancement from T1-T8 with a non-enhancing nodular cystic lesion at T1-2, suspicious for LETM. Brain MRI, CT chest, and neuro-ophthalmic exam were unremarkable. CSF for infection and inflammation revealed a mildly elevated protein. Aquaporin 4 and MOG antibodies were negative. High-dose steroids and PLEX provided minimal improvement. One year prior to presentation, he suffered a penetrating stab wound to the spine that did not pierce the dura, but resulted in left hemisensory loss and mild left weakness. Prior MRI spine demonstrated T2 signal at T1-2 contiguous with an external penetrating injury. His presenting symptoms were attributed to acute progression of his prior spinal cord trauma precipitated by heavy weight lifting.

Post-traumatic progressive myelopathy (PTPM) is an under-recognized but important cause of myelopathy in patients with prior spinal cord injury. Our patient likely experienced an acute on chronic secondary inflammatory response clinically and radiologically manifesting as LETM. PTPM is an important etiology to consider before initiating chronic immunosuppressive therapy that may not benefit the patient.

Authors/Disclosures
LynnMarie Jarratt, MD
PRESENTER
Dr. Jarratt has nothing to disclose.
Narges Moghimi, MD (University of New Mexico) Dr. Moghimi has nothing to disclose.
Diana Greene-Chandos, MD, FAAN (St. Louis University SOM/SSM Health, Dept of Neurology) The institution of an immediate family member of Dr. Greene-Chandos has received research support from NIH Stroke NET .
Christine Meadows, MD Dr. Meadows has nothing to disclose.
Clotilde Hainline, MD (University of New Mexico) Dr. Hainline has nothing to disclose.